The Risk of Stroke or Clinical Impairment After Stereotactic Radiosurgery for ARUBA-Eligible Patients [Original Contributions]

Conclusions— The observed risk of stroke or death after SRS was approximately 2% per year for the first 5 years after SRS, declining to 0.2% annually for years 6 to 10. Patients with small volume BAVM may benefit from SRS compared with the natural history of unruptured BAVM over the planned follow-up interval of the ARUBA trial (5–10 years).

http://stroke.ahajournals.org/cgi/content/short/44/2/437?rss=1

Source: Stroke - January 18, 2013 Category: Neurology Authors: Pollock, B. E., Link, M. J., Brown, R. D. Tags: Cerebral Aneurysm, AVM, & Subarachnoid hemorrhage, Other Stroke Treatment - Surgical Original Contributions Source Type: research